99873-30-0

Usage

Uses

Used in Pharmaceutical Industry:
Phenol, 4-bromo-3-ethylis used as an intermediate in the production of pharmaceuticals for its unique chemical properties that can be utilized in the synthesis of various medicinal compounds.
Used in Dye and Perfume Industry:
Phenol, 4-bromo-3-ethylis used as a component in the creation of dyes and perfumes, where its distinct odor and color characteristics contribute to the final product's quality.
Used in Organic Synthesis:
Phenol, 4-bromo-3-ethylserves as a valuable intermediate in organic synthesis, enabling the development of a range of chemical products through its reactive functional groups.
Used in Agricultural Chemicals:
Phenol, 4-bromo-3-ethylis used as an intermediate in the manufacture of fungicides, contributing to the development of agricultural products that protect crops from fungal infections.
Used in Antiseptics Production:
Phenol, 4-bromo-3-ethylis utilized in the production of antiseptics, where its properties help in the formulation of products designed to prevent infection and maintain hygiene.

Upstream product

• 620-17-7 3-ethylphenol 

Downstream Products

• 1116624-31-7 (2S)-2-(4-bromo-3-ethylphenoxy)methyl-4-methyl-3,4-dihydro-2H-1,4-benzoxazine 
• 1279014-72-0 (S)-2-(2-ethyl-2',3'-dimethyl-biphenyl-4-yloxymethyl)-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-one 

Relevant academic research and scientific papers

Synthesis of natural product inulavosin via Ga(OTf)3-Catalyzed Hetero Diels–Alder Dimerization of salicyl alcohol derivative

Inulavosin, a natural melanogenesis inhibitor, has been synthesized smoothly from readily available and inexpensive starting materials by using a Ga(OTf)3-catalyzed room temperature hetero Diels–Alder dimerization of salicyl alcohol derivative and a regioselective phenol monobromination as the key steps.

Tetrazolinone compound, and use therefor

A tetrazolinone compound represented by formula (1) (in the formula, R1, R2, R3, and R11 each represent a halogen atom, a C1-C6 alkyl group, or the like; R4 and R5 each represent a hydrogen atom, a halogen atom, a C1-C3 alkyl group, or the like; R6 represents a C1-C3 alkyl group which may have one or more halogen atoms, or the like; R7 R8, and R9 each represent a hydrogen atom, a halogen atom, or the like; R10 represents a C1-C3 alkyl group, or the like; and R12 represents a phenyl group which may have one or more atoms or groups selected from group (P3), a phenoxy group which may have one or more atoms or groups selected from group (P3), or the like). The tetrazolinone compound has an excellent pest-control effect.

TETRAZOLINONE COMPOUND AND USE THEREOF

A tetrazolinone compound represented by formula (1): Wherein R1, R2, R3, and R11 each represents a halogen atom, a C1-C6 alkyl group, etc.; R4 and R5 each represents a hydrogen atom, a halogen atom, a C1-C3 alkyl group, etc.; R6 represents a C1-C3 alkyl group optionally having one or more halogen atoms, etc.; R7, R8, and R9 each represents a hydrogen atom, a halogen atom, etc.; R10 represents a C1-C3 alkyl group, etc.; and R12 represents a phenyl group optionally having one or more atoms or groups selected from Group P3, a phenoxy group optionally having one or more atoms or groups Group P3, etc., has excellent control activity against pests.

SUBSTITUTED PARA-BIPHENYLOXYMETHYL DIHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF

The present invention relates to a series of substituted para-biphenyloxymethyl dihydro oxazolopyrimidinones of formula (I) as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of

PHENYLACETIC ACID COMPOUND

A compound represented by formula (I), wherein R1 represents a hydrogen atom, etc., R2 and R3 each independently represents a hydrogen atom, optionally oxidized C1-4 alkyl group or optionally protected hydroxyl group, or R2 and R3 taken together represent optionally oxidized C2-5 alkylene group, R4 represents an optionally oxidized C1-6 alkyl group, etc., R5 represents an optionally oxidized C1-6 alkyl group, etc., R6 represents an optionally oxidized C1-6 alkyl group, etc., m represents 0 or an integer from 1 to 3, n represents 0 or an integer from 1 to 4, and i represents 0 or an integer from 1 to 7.

AMINO ALCOHOL DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USE OF THESE

The present invention provides compounds represented by general formula (I): a prodrug thereof, or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; each of R2 and R3 is independently hydrogen or lower alkyl; each of R4, R5 and R6 is independently hydrogen, halogen, lower alkyl or lower alkoxy; R7 is hydrogen or lower alkyl; R8 is hydrogen, halogen, lower alkyl, lower alkoxy, etc; R9 is -COR10, -A1-COR10, -O-A2-COR10, etc; Ar is optionally substituted phenyl or heteroaryl; and A is a bond, -OCH2-, etc, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.

AMINO ALCOHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE THEREOF

The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 and R2 are each hydrogen or lower alkyl; R3 R4, R5 and R6 are each hydrogen, halogen, lower alkyl or lower alkoxy; R7 and R8 are each hydrogen, halogen, lower alkyl, halo-lower alkyl, lower alkoxy, cycloalkyl, aryl, heteroaryl, cyano, a hydroxyl group, lower acyl, carboxy or the like; R9 is -C(O)-R10, -A1-C(O)-R10, -O-A2-C(O)-R10 or a tetrazol-5-yl group, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.

Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.